Frederick Raal to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Frederick Raal has written about Clinical Trials, Phase I as Topic.
Connection Strength
0,114
-
Reduction of low-density lipoprotein cholesterol by monoclonal antibody inhibition of PCSK9. Annu Rev Med. 2014; 65:417-31.
Score: 0,114